Aclaris Therapeutics (ACRS) Other financing activities (as filed) (2015 - 2026)
Aclaris Therapeutics (ACRS) recorded Other financing activities (as filed) of -$23,000 in Q2 2026, compared with -$9,000 a year earlier.
Powered by 
Analysis
Aclaris Therapeutics (ACRS) Other financing activities (as filed) (2015 - 2026) Analysis & Trends
On a TTM basis, Aclaris Therapeutics' Other financing activities (as filed) came in at -$5.85 million as of Jun 30, 2026; for FY2025, it came in at -$5.86 million.
- Across earlier years, Other financing activities (as filed) came in at -$409,000 in FY2024, -$102,000 in FY2023, -$34,000 in FY2022 and -$3.12 million in FY2021.
- Quarterly Other financing activities (as filed) has ranged from -$3.04 million in Q3 2025 to -$2,000 in Q4 2021 over the past five years.
- Per Business Quant, the preceding three quarters came in at -$250,000 (Q1 2026), -$2.53 million (Q4 2025) and -$3.04 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,264.65 Bn | 1,238.27 Bn | 20.46 Bn |
| 2 | Johnson & Johnson | 677.74 Bn | 597.60 Bn | 17.30 Bn |
| 3 | AbbVie | 517.10 Bn | 485.11 Bn | 13.12 Bn |
| 4 | Merck | 362.23 Bn | 325.17 Bn | 13.19 Bn |
| 5 | Novartis Ag | 315.90 Bn | 276.16 Bn | 11.24 Bn |
| 6 | Astrazeneca | 289.40 Bn | 266.24 Bn | 12.86 Bn |
| 7 | Amgen | 249.90 Bn | 201.56 Bn | 7.58 Bn |
| 8 | Gilead Sciences | 209.15 Bn | 184.26 Bn | 6.73 Bn |
| 9 | Pfizer | 165.88 Bn | 113.23 Bn | 12.56 Bn |
| 10 | Aclaris Therapeutics | 638.89 Mn | 236.88 Mn | 1.29 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | -63,000.00 |
| Jun 30, 2026 | -23,000.00 |
| Mar 31, 2026 | -250,000.00 |
| Dec 31, 2025 | -2.53 Mn |
| Sep 30, 2025 | -3.04 Mn |
| Jun 30, 2025 | -9,000.00 |
| Mar 31, 2025 | -275,000.00 |
| Dec 31, 2024 | -333,000.00 |
| Sep 30, 2024 | -10,000.00 |
| Jun 30, 2024 | -11,000.00 |
| Mar 31, 2024 | -55,000.00 |
| Sep 30, 2022 | -11,000.00 |
| Jun 30, 2022 | -16,000.00 |
| Mar 31, 2022 | -7,000.00 |
| Dec 31, 2021 | -2,000.00 |
| Sep 30, 2021 | -84,000.00 |
| Jun 30, 2021 | -24,000.00 |
| Mar 31, 2021 | -3.01 Mn |
| Dec 31, 2020 | 31,000.00 |
| Sep 30, 2015 | -612,000.00 |
API Access
Aclaris Therapeutics Other financing activities (as filed) API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=other-financing-activities&ticker=ACRS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "other-financing-activities", "ticker": "ACRS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=other-financing-activities&ticker=ACRS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();